Late-Breaking Abstract Submission

The late-breaking abstract submission is intended for highly significant and timely scientific or clinical findings that were not available by the regular abstract submission deadline (15 April 2026).

Submissions may include recently completed studies, newly available clinical trial results, important scientific discoveries or other emerging data with the potential to advance knowledge, influence clinical practice or inform future research.

Further details regarding submission guidelines, eligibility criteria and access to the submission platform will be shared here shortly.

In the meantime, mark the dates in your calendar and stay tuned for further information.